TW200716589A - Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole - Google Patents

Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole

Info

Publication number
TW200716589A
TW200716589A TW095112190A TW95112190A TW200716589A TW 200716589 A TW200716589 A TW 200716589A TW 095112190 A TW095112190 A TW 095112190A TW 95112190 A TW95112190 A TW 95112190A TW 200716589 A TW200716589 A TW 200716589A
Authority
TW
Taiwan
Prior art keywords
preparation
oxepino
dibenz
pyrrole
tetrahydro
Prior art date
Application number
TW095112190A
Other languages
English (en)
Inventor
Gerardus Johannes Kemperman
Der Linden Jacobus Johannes Maria Van
Michael R Reeder
Original Assignee
Organon Ireland Ltd
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Ireland Ltd, Pfizer filed Critical Organon Ireland Ltd
Publication of TW200716589A publication Critical patent/TW200716589A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
TW095112190A 2005-04-07 2006-04-06 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole TW200716589A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05102742 2005-04-07

Publications (1)

Publication Number Publication Date
TW200716589A true TW200716589A (en) 2007-05-01

Family

ID=35511130

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095112190A TW200716589A (en) 2005-04-07 2006-04-06 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole

Country Status (28)

Country Link
EP (2) EP2154134B1 (zh)
JP (1) JP2008534657A (zh)
KR (1) KR20070116973A (zh)
CN (2) CN101175741B (zh)
AR (1) AR063188A1 (zh)
AT (1) ATE447564T1 (zh)
AU (1) AU2006231281B2 (zh)
BR (1) BRPI0610677A2 (zh)
CA (1) CA2603181A1 (zh)
CY (1) CY1109722T1 (zh)
DE (1) DE602006010132D1 (zh)
DK (1) DK1710241T3 (zh)
ES (1) ES2333980T3 (zh)
HK (1) HK1094800A1 (zh)
HR (1) HRP20100031T1 (zh)
IL (1) IL186354A0 (zh)
MX (1) MX2007012446A (zh)
NO (1) NO20075152L (zh)
NZ (1) NZ562125A (zh)
PL (1) PL1710241T3 (zh)
PT (1) PT1710241E (zh)
RS (1) RS51341B (zh)
RU (1) RU2397164C2 (zh)
SI (1) SI1710241T1 (zh)
TW (1) TW200716589A (zh)
UA (2) UA93043C2 (zh)
WO (1) WO2006106136A1 (zh)
ZA (2) ZA200708493B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5027477B2 (ja) * 2005-10-21 2012-09-19 住友化学株式会社 ジベンゾオキセピノピロール化合物およびその中間体の製造方法ならびに新規中間体
TW200817414A (en) * 2006-07-05 2008-04-16 Organon Nv Process for the preparation of asenapine and intermediate products used in said process
CN101563312A (zh) * 2006-12-22 2009-10-21 住友化学株式会社 阿塞那平合成中间体的制备方法
US7875729B2 (en) * 2007-01-05 2011-01-25 Synthon Bv Process for making asenapine
JP5245428B2 (ja) 2007-07-06 2013-07-24 住友化学株式会社 トランス−ジベンゾオキセノピロール化合物の製造方法およびその中間体
CA2710800A1 (en) * 2008-01-04 2009-07-16 N.V. Organon Process for the preparation of asenapine and intermediate products used in said process
TW201113018A (en) 2009-06-24 2011-04-16 Organon Nv Injectable formulations containing asenapine and method of treatment using same
CN101851242B (zh) * 2010-05-25 2013-07-24 上海皓元生物医药科技有限公司 阿塞那平中间体的制备方法
EP2598496B1 (en) 2010-07-29 2014-03-19 Laboratorios Lesvi, S.L. Novel process for the preparation of asenapine
WO2012038975A2 (en) * 2010-09-22 2012-03-29 Msn Laboratories Limited Process for the preparation of (3ars,12brs)-5-chloro-2-methyl-2,3,3a12b-tetrahydro-1hdibenzo[2,3:6,7] oxepino [4,5-c]pyrrole maleate and it's pharmaceutical composition thereof
EP2468751B1 (en) 2010-12-24 2016-03-16 Medichem, S.A. Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
ITMI20110734A1 (it) * 2011-05-02 2012-11-03 Olon Spa Sali cristallini di asenapina
WO2013024492A2 (en) 2011-07-01 2013-02-21 Megafine Pharma (P) Ltd. A process for the preparation of asenapine and novel salts thereof
CN102952144A (zh) * 2011-08-29 2013-03-06 上海华拓医药科技发展股份有限公司 阿森纳平马来酸盐的晶型、制备方法及其药物组合物
WO2013080069A1 (en) * 2011-11-28 2013-06-06 Ranbaxy Laboratories Limited Process for the preparation of asenapine intermediate
CN102746209A (zh) * 2012-06-20 2012-10-24 盛世泰科生物医药技术(苏州)有限公司 一种3-（2-（4-氯苯氧基）苯基）-1-甲基-2,4-二酮的合成方法
CN103965206A (zh) * 2013-01-29 2014-08-06 北京京卫燕康药物研究所有限公司 一种阿色纳品马来酸盐的新晶型及制备方法
CN103113379A (zh) * 2013-03-12 2013-05-22 盛世泰科生物医药技术(苏州)有限公司 阿塞那平马来酸盐的合成工艺
CN103254202A (zh) * 2013-05-19 2013-08-21 甘肃皓天化学科技有限公司 阿塞纳平的制备方法
CN103342707B (zh) * 2013-06-28 2015-09-02 甘肃皓天化学科技有限公司 用于制备阿塞纳平中间体的制备方法
CN104447771A (zh) * 2013-09-12 2015-03-25 天津市汉康医药生物技术有限公司 一种稳定的马来酸阿塞那平化合物
CN103864802B (zh) * 2014-03-31 2016-08-17 四川科伦药业股份有限公司 马来酸阿塞那平的制备方法
CN105693735A (zh) * 2016-01-15 2016-06-22 万特制药(海南)有限公司 马来酸阿塞那平一种制备方法
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
CN109200025A (zh) * 2017-06-29 2019-01-15 哈尔滨莱博通药业有限公司 一种阿森纳平马来酸盐舌下片
WO2019243452A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
CN110183457A (zh) * 2019-06-27 2019-08-30 浙江天顺药业有限公司 一种阿塞那平及其制备方法
CN112194665A (zh) * 2020-10-20 2021-01-08 连云港杰瑞药业有限公司 一种合成阿塞那平中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7605526A (nl) * 1976-05-24 1977-11-28 Akzo Nv Nieuwe tetracyclische derivaten.
HU225051B1 (en) 1994-03-02 2006-05-29 Organon Ireland Ltd Sublingual or buccal pharmaceutical compositions containing trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole
WO1999032108A1 (en) 1997-12-19 1999-07-01 Akzo Nobel N.V. Org-5222 in the treatment of depression

Also Published As

Publication number Publication date
CA2603181A1 (en) 2006-10-12
RU2007141161A (ru) 2009-05-20
ATE447564T1 (de) 2009-11-15
EP1710241A1 (en) 2006-10-11
ZA200708493B (en) 2009-09-30
CN101175741A (zh) 2008-05-07
DK1710241T3 (da) 2010-03-01
AR063188A1 (es) 2009-01-14
DE602006010132D1 (de) 2009-12-17
CN101175741B (zh) 2011-06-22
UA93044C2 (en) 2011-01-10
HK1094800A1 (en) 2007-04-13
SI1710241T1 (sl) 2010-02-26
CN1861604A (zh) 2006-11-15
EP2154134A1 (en) 2010-02-17
CY1109722T1 (el) 2014-04-09
MX2007012446A (es) 2007-11-07
AU2006231281B2 (en) 2011-04-28
AU2006231281A1 (en) 2006-10-12
PT1710241E (pt) 2009-12-10
EP1710241B1 (en) 2009-11-04
CN1861604B (zh) 2011-08-31
KR20070116973A (ko) 2007-12-11
NO20075152L (no) 2007-11-01
UA93043C2 (ru) 2011-01-10
ES2333980T3 (es) 2010-03-03
RU2397164C2 (ru) 2010-08-20
RS51341B (en) 2011-02-28
JP2008534657A (ja) 2008-08-28
BRPI0610677A2 (pt) 2012-10-30
IL186354A0 (en) 2008-01-20
HRP20100031T1 (hr) 2010-02-28
EP2154134B1 (en) 2012-10-24
NZ562125A (en) 2010-08-27
ZA200708490B (en) 2008-10-29
WO2006106136A1 (en) 2006-10-12
PL1710241T3 (pl) 2010-04-30

Similar Documents

Publication Publication Date Title
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
MX2007006397A (es) Derivados de tetrahidropirano.
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
TW200800969A (en) Compounds
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
RS20050769A (en) Derivatives of 2-acylamino-4- phenylthiazole,preparation method thereof and application of same in therapeutics
GEP20135780B (en) Novel pyrazolo [3,4-d] pyrimidine derivatives as anti-cancer agents
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
WO2008049758A3 (de) Dispersionsfarbstoffe, ihre herstellung und ihre verwendung
WO2006125555A3 (de) Chinazolinone
HK1150597A1 (zh)
TW200626600A (en) Octahydropyrrolo[3, 4-c]pyrrole derivatives
HK1145172A1 (en) (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
TW200745102A (en) Pyrido[2,3-d]pyrimidine derivatives, preparation thereof, therapeutic use thereof
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
RS51912B (en) 1,2,3,4-TETRAHYDROPYROLO (1,2-a) PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYROLO (1,2-a) (1,4) -DIAZEPIN-7-CARBOXAMIDE DERIVATIVES THEIR OBTAINING AND THERAPEUTIC APPLICATION
EP1673384A4 (en) NITROSED GLUTAMIC ACID COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF USE
SG152296A1 (en) Novel process for the preparation of 5-amino-3h-thiazolo[4,5-d]pyrimidin-2- one
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
IL164978A0 (en) A process for the preparation of clopidogrel
IS8034A (is) Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla
DE602005026035D1 (en) Festphasenpeptidsynthese